ATRA Atara Bio Operatsion rentabellik

Ommaviy kompaniya Atara Bio (ATRA) logotipi

Atara Biotherapeutics (ATRA) skleroz terapiyasi sohasida yuqori rentabelli aktivni ishlab chiqmoqda, buni operatsion marja egri chizig'i tasdiqlaydi, bunda joriy qiymat -358.40 ni tashkil etadi. Biznes barqarorligi kompaniyaning shaxsiy T-hujayrali mahsulotlar ishlab chiqarish zavodi bilan ta'minlanadi. Shu bilan birga, risklar klinik sikllar va sog'liqni saqlash gigantlari bilan tuzilgan strategik ittifoqlar orqali yumshatiladi, bu esa kechki bosqichdagi sinovlarni tashqi zarbalardan himoya qiladi.

ATRA: Atara Biotherapeutics Operatsion marja 04.07.2022 - 19.11.2026

Atara Biotherapeutics, Inc. (ATRA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning dastlabki tahlili:ATRA, Atara Biotherapeutics
Atara Bio tayyor mahsulotlari

Operatsion marja xarajatlarni boshqarish samaradorligini aks ettirib, moliyaviy xarajatlar va soliqlarni hisobga olguncha asosiy operatsiyalardan olingan foyda ulushini ko'rsatadi. Operatsion marjani tahlil qilish orqali investor Atara Biotherapeutics (ATRA) biznes modelining barqarorligini baholaydi, bunda Yevropa distribyutsiya hamkori bilan strategik ittifoq yangi T-hujayrali terapiyalarni ishlab chiqish bilan bog'liq yuqori xavflarni yumshatishga va operatsion pul oqimini barqarorlashtirishga yordam beradi.

Atara Biotherapeutics raqobatchilari

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion marja ADMA Biologics, Inc. (ADMA)|Operatsion marja PTGX (protagonist-inc.com)|IMVT: Operatsion foyda bo'yicha sotuv rentabelligi|KNSA - Operatsion rentabellik|GRFS: Operatsion rentabellik|ADPT (Adaptive Biotechnologies) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CLDX|Sotuvning operatsion marjasi AUPH|BCRX (BioCryst Pharmaceuticals) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operatsion foyda normasi|Pharvaris N.V. - Sotuvning operatsion marjasi|Operatsion foyda normasi ABCL|TRML: Sotuvning operatsion marjasi|PGEN (Precigen) - Operatsion foyda bo'yicha sotuv rentabelligi|pharming.com (PHAR) - Operatsion rentabellik|Nektar Corp (NKTR) - Operatsion marja|UPB (upstreambio.com) - Operatsion marja|ZBIO: Operatsion foyda normasi|Operatsion marja IMNM|Operatsion faoliyat rentabelligi Gossamer Bio Inc|Operatsion marja KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operatsion foyda marjasi|PVLA: Sotuvning operatsion marjasi|Operatsion foyda marjasi SVRA|RIGL: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ANAB|ATXS (Astria Corp) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ENGN (enGene Bio)|Operatsion marja RAPT|Operatsion faoliyat rentabelligi Aerovate Therapeutics|Operatsion rentabellik Aclaris Therapeutics Inc. ACRS|Operatsion faoliyat rentabelligi Kyverna Therapeutics Inc. (KYTX)|TLSA - Operatsion rentabellik|CABA: Operatsion rentabellik|VTYX (Ventyx Biosciences, Inc.) - Sotuvning operatsion marjasi|THTX - Operatsion faoliyat rentabelligi|AVTX (avalotx.com) - Operatsion marja|Sotuvning operatsion rentabelligi Eledon Pharmaceuticals Inc. ELDN|Operatsion marja AGEN|CLYM (Climb Bio, Inc.) - Operatsion foyda normasi|Operatsion rentabellik zurabio.com ZURA|ATYR - Sotuvning operatsion marjasi|Adagene Inc - Operatsion marja|ImageneBio (IMA) - Sotuvning operatsion marjasi|Shattuck Therapeutics (STTK) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Equillium Inc (EQ)|Sotuvning operatsion marjasi CNTB|Operatsion foyda bo'yicha sotuv rentabelligi IMUX (Immunic, Inc.)|Operatsion marja IFRX|Operatsion marja X4 Pharma (XFOR)|Operatsion marja ACET (adicetbio.com)|Operatsion marja Celularity Inc. CELU|INMB - Operatsion rentabellik|Operatsion foyda normasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi SAB Biotherapeutics Inc.|Sotuvning operatsion marjasi AKTX|Sotuvning operatsion marjasi enlivex.com (ENLV)|Operatsion rentabellik Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operatsion foyda bo'yicha marjinallik|Operatsion marja EDSA (Edesa Biotech Corp)|Operatsion faoliyat rentabelligi iBio (IBIO)|CARM - Operatsion rentabellik|XTL Biopharmaceuticals (XTLB) - Sotuvning operatsion marjasi|BOLT: Operatsion marja|Sotuvning operatsion marjasi HCW Biologics Inc.|Operatsion rentabellik Aptevo|Operatsion foyda bo'yicha sotuv rentabelligi AIM (AIM ImmunoTech, Inc.)|Operatsion marja ADTX|Operatsion faoliyat rentabelligi GRI Bio Corp|Operatsion marja XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com